PRF Technologies Ltd. (PRFX)
NASDAQ: PRFX · Real-Time Price · USD
0.8993
-0.0462 (-4.89%)
Jan 22, 2026, 1:04 PM EST - Market open
Company Description
PRF Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on the reformulation of established therapeutics and provides an extended period of post-surgical pain relief in Israel.
It develops PRF-110, a viscous clear oil-based solution that is instilled directly into the surgical wound to provide localized and extended post-operative analgesia, as well as in Phase 3 clinical trial for pain treatment of patients undergoing bunionectomy and pain treatment of hernia repair operations.
The company was formerly known as PainReform Ltd. and change its name to PRF Technologies Ltd. in January 2026.
The company was incorporated in 2007 and is based in Tel Aviv, Israel.
PRF Technologies Ltd.
| Country | Israel |
| Founded | 2007 |
| IPO Date | Sep 1, 2020 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 6 |
| CEO | Ehud Geller |
Contact Details
Address: 65 Yigal Alon St. Tel Aviv, 6744316 Israel | |
| Phone | 972 3 7177050 |
| Website | painreform.com |
Stock Details
| Ticker Symbol | PRFX |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $8.00 |
| CIK Code | 1801834 |
| CUSIP Number | M77798102 |
| ISIN Number | IL0011651580 |
| SIC Code | 2834 |
Key Executives
| Name | Position |
|---|---|
| Dr. Ehud Geller Ph.D. | Interim Chief Executive Officer and Executive Chairman |
| Dr. Sigal Aviel eMBA, Ph.D. | Chief Operating Officer |
| Prof. Eli Hazum Ph.D. | Chief Technology Officer and Director |
| Rita Keynan | Vice President of Pharmaceutical Operations |
| Dr. Stephen A. Cooper D.M.D Ph.D. | Executive Vice President of Development |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 20, 2026 | 6-K | Report of foreign issuer |
| Jan 15, 2026 | 6-K | Report of foreign issuer |
| Jan 12, 2026 | 6-K | Report of foreign issuer |
| Jan 7, 2026 | 6-K | Report of foreign issuer |
| Jan 6, 2026 | 6-K | Report of foreign issuer |
| Jan 5, 2026 | 6-K | Report of foreign issuer |
| Dec 30, 2025 | 6-K | Report of foreign issuer |
| Dec 10, 2025 | 6-K | Report of foreign issuer |
| Dec 2, 2025 | 6-K | Report of foreign issuer |
| Nov 25, 2025 | 6-K | Report of foreign issuer |